|
Re: SP 884+ Week Low.
|
1
|
Resverlogix Corp.
|
Oct 16, 2022 12:08PM
|
|
Re: SP 884+ Week Low.
|
7
|
Resverlogix Corp.
|
Oct 16, 2022 02:49PM
|
|
Re: Fun with Numbers
|
2
|
Resverlogix Corp.
|
Oct 18, 2022 01:43PM
|
|
Re: from IR "Hepalink does not own Zenith shares."
|
2
|
Zenith Epigenetics
|
Oct 24, 2022 03:49PM
|
|
Re: from IR "Hepalink does not own Zenith shares."
|
2
|
Zenith Epigenetics
|
Oct 24, 2022 08:48PM
|
|
Re: USA ZHCLF investors
|
2
|
Zenith Epigenetics
|
Oct 28, 2022 10:15PM
|
|
BearDownAZ AGM presentation
|
|
Zenith Epigenetics
|
Oct 29, 2022 02:36PM
|
|
Potential Deals
|
2
|
Zenith Epigenetics
|
Oct 29, 2022 02:49PM
|
|
Re: USA ZHCLF investors
|
1
|
Zenith Epigenetics
|
Nov 01, 2022 12:02PM
|
|
Re: USA ZHCLF investors
|
4
|
Zenith Epigenetics
|
Nov 02, 2022 02:36PM
|
|
Re: Toxicity
|
3
|
Zenith Epigenetics
|
Nov 02, 2022 09:26PM
|
|
Re: USA ZHCLF investors
|
1
|
Zenith Epigenetics
|
Nov 02, 2022 09:41PM
|
|
Re: Toxicity
|
4
|
Zenith Epigenetics
|
Nov 03, 2022 04:08PM
|
|
Re: find it interesting that RVXCF.....
|
7
|
Resverlogix Corp.
|
Nov 10, 2022 07:32PM
|
|
Re: find it interesting that RVXCF.....
|
3
|
Resverlogix Corp.
|
Nov 11, 2022 07:47PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 14, 2022 05:12PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 15, 2022 12:21PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 18, 2022 09:06PM
|
|
Two big thank you’s
|
|
Zenith Epigenetics
|
Nov 24, 2022 01:46PM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 07:41PM
|
